Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

Abstract Background Glucocorticoids are associated with increased fracture risk and are the mainstay of treatment in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). However, fracture risk in these conditions has not been previously quantified. The aim of this study was to quantify the r...

Full description

Bibliographic Details
Main Authors: Zoe Paskins, Rebecca Whittle, Alyshah Abdul Sultan, Sara Muller, Milica Blagojevic-Bucknall, Toby Helliwell, Samantha Hider, Edward Roddy, Christian Mallen
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Medicine
Subjects:
Fracture
Osteoporosis
Glucocorticoids
Polymyalgia
Giant cell arteritis
Online Access:http://link.springer.com/article/10.1186/s12916-017-0987-1

Internet

http://link.springer.com/article/10.1186/s12916-017-0987-1

Similar Items